Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CoreWeave, Inc. entered into a new order form with Meta Platforms, Inc. under their existing master services agreement. Under this order, Meta has initially committed to pay CoreWeave up to approximately $14.2 billion for cloud computing capacity through December 14, 2031, subject to delivery and service availability requirements and potential termination rights. Meta also has an option to materially expand its commitment through 2032 for additional capacity. The master services agreement will remain in place until all outstanding orders expire or are terminated, and it includes customary representations, warranties, indemnification and limitations of liability.
Michael N. Intrator, CoreWeave (CRWV) CEO, reported transactions on 09/24/2025. He acquired 50,000 Class B shares (convertible into Class A) and executed multiple sales of Class A shares through Omnadora Capital LLC under a Rule 10b5-1 plan adopted May 23, 2025. The sales were executed in multiple tranches at weighted-average prices reported in ranges from $124.47 to $133.41 per share across the transactions listed. The filing shows various beneficial ownership positions after each sale and lists material holdings tied to Omnadora and several trusts and family vehicles, including 21,867,489 Class A (direct) and 25,499,280 Class A (indirect) positions referenced for different holdings.
CoreWeave, Inc. (CRWV) Form 4 disclosure describes multiple insider sales by affiliated reporting persons tied to Magnetar entities and an individual manager. On 09/25/2025 the filing reports a series of dispositions totaling 185,627 shares of Class A common stock sold across multiple transactions at weighted-average prices in the range of roughly $135.94 to $138.00 per share. The reporting chain shows Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman as related reporting persons, with the sold shares held by various Magnetar funds. After the transactions the filing shows an indicated indirect beneficial ownership position of 9,202,863 shares for certain affiliated accounts. The filing includes detailed footnotes explaining the fund relationships and weighted-average price ranges.
Magnetar-related entities and David J. Snyderman reported multiple dispositions of CoreWeave, Inc. (CRWV) Class A common stock on 09/25/2025. The Form 4 shows numerous sales in separate blocks at weighted-average prices ranging roughly from $133.50 to $138.00 per share. The filings identify Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman as reporting persons, each noted as a director and a 10% owner or connected to such funds. The report lists the number of shares beneficially owned following each reported sale for various underlying funds and accounts and includes footnotes describing the holding entities and price ranges.
CoreWeave officer McBee reported multiple transactions on 09/23/2025 involving both Class A and Class B common stock. The filing shows conversions of 250,000 and 375,000 shares of Class B into Class A, and a series of sales under a Rule 10b5-1 plan that disposed of many Class A shares in tranches priced between about $127.17 and $136.00 per share.
The reporting person holds direct and indirect interests through the Brannin J. McBee 2022 Irrevocable Trust and several family trusts; some shares remain indirectly held for family trusts. The Form 4 was signed by an attorney-in-fact on 09/25/2025 and discloses that the sales were effected pursuant to a 10b5-1 trading plan adopted May 20, 2025.
CoreWeave (CRWV) and Core Scientific (CORZ) have entered into a definitive merger agreement under which Merger Sub will merge into Core Scientific and Core Scientific will become a wholly owned subsidiary of CoreWeave. Each outstanding share of Core Scientific common stock (other than excluded shares) will be converted into the right to receive 0.1235 shares of CoreWeave common stock. Based on CoreWeaveâs closing price of $165.20 on July 3, 2025, the exchange ratio implied approximately $20.40 per Core Scientific share. The Core Scientific board unanimously recommends the Merger and received fairness opinions from Moelis and PJT Partners. The transaction requires Core Scientific stockholder approval, regulatory clearances including the HSR waiting period, effectiveness of the S-4 registration statement, Nasdaq listing approval for issued CoreWeave shares, and other customary conditions. Core Scientific stockholders have no dissentersâ or appraisal rights and certain Core Scientific equity awards and convertible notes will be adjusted or converted per the Merger Agreement. A $270 million termination fee applies in specified circumstances.
CoreWeave, Inc. disclosed a Master Services Agreement (MSA) with OpenAI OpCo, LLC dated May 8, 2025. The filing states the MSA will remain in effect until all outstanding orders expire or the MSA is otherwise terminated under its terms. Either party may terminate the MSA or any order for cause. The agreement includes customary provisions covering representations and warranties, indemnification, and limitations on liabilities. The document also notes the cover page is provided in Inline XBRL and is signed by CEO Michael Intrator.
CoreWeave, Inc. GC and Secretary Kristen J. McVeety reported that the Jackfruit 2024 GRAT, for which she is the sole trustee and beneficiary, sold 95,000 shares of Class A Common Stock on September 22, 2025 in multiple open-market or private transactions.
The filing notes weighted-average prices across tranches, with examples of ranges such as $119.71–$120.69 and $135.50–$136.20 per share, and states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2025. Following these transactions, the Jackfruit 2024 GRAT held 0 shares of Class A Common Stock.
Form 144 notice for CoreWeave, Inc. (CRWV): The filing reports a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $6,544,500, scheduled for 09/24/2025 on NASDAQ. The shares were acquired as founders' shares on 11/13/2017. The filing also lists recent 10b5-1 sales: two sales on 09/10/2025 and two on 08/27/2025, by Michael Intrator and Omnadora Capital LLC, with gross proceeds shown for each transaction. The notice includes the standard representation that the seller knows of no undisclosed material adverse information.
Form 144 notice for CoreWeave, Inc. (CRWV) reports a proposed sale of 32,455 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $4,248,034.95 and approximately 370,470,348 shares outstanding. The filing lists the shares as acquired 02/23/2020 in connection with Series A preferred stock conversion or transaction and shows the approximate sale date as 09/24/2025 on NASDAQ. The filing also discloses multiple recent 10b5-1 sales during August and September 2025 by Michael Intrator and Omnadora Capital LLC, totaling four transactions listed with gross proceeds of $3,840,276.82, $5,916,310.00, $3,104,307.77, and $4,782,480.00 respectively. The notice includes the standard certification that the seller is not aware of undisclosed material adverse information.